Your Source for NPR News & Music

FDA Expected To Approve Esketamine Nasal Spray For Depression

By Jon Hamilton
Published March 4, 2019 at 5:41 PM MST
  • Facebook
  • Twitter
  • LinkedIn
  • Email

Your browser doesn’t support HTML5 audio

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

  • Facebook
  • Twitter
  • LinkedIn
  • Email
Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
See stories by Jon Hamilton
Related Stories
  1. Texas charging another large group of migrants with “riot participation”
  2. El Pasoans catch glimpse of solar eclipse
  3. Texas criminally charges more than 200 migrants involved in alleged “riot” at the border
  4. Lebanese migrant allegedly tied to terrorist group appears in federal court with a black eye